[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1115636T1 - Substituted aryl-indole compounds and the kinurenine metabolites / metabolites that resemble their cynuramine as therapeutic agents - Google Patents

Substituted aryl-indole compounds and the kinurenine metabolites / metabolites that resemble their cynuramine as therapeutic agents

Info

Publication number
CY1115636T1
CY1115636T1 CY20141100822T CY141100822T CY1115636T1 CY 1115636 T1 CY1115636 T1 CY 1115636T1 CY 20141100822 T CY20141100822 T CY 20141100822T CY 141100822 T CY141100822 T CY 141100822T CY 1115636 T1 CY1115636 T1 CY 1115636T1
Authority
CY
Cyprus
Prior art keywords
metabolites
cynuramine
substituted aryl
kinurenine
resemble
Prior art date
Application number
CY20141100822T
Other languages
Greek (el)
Inventor
Tal Peleg-Shulman
Moshe Laudon
Dvorah Daily
Original Assignee
Neurim Pharmaceuticals (1991) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07859335.7A external-priority patent/EP2086932B1/en
Application filed by Neurim Pharmaceuticals (1991) Limited filed Critical Neurim Pharmaceuticals (1991) Limited
Publication of CY1115636T1 publication Critical patent/CY1115636T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αυτή κατευθύνεται σε υποκατεστημένες αρυλ-ενώσεις, οι οποίες συνδέονται σε μια χαρακτηριστική ομάδα υποκατεστημένου ινδολίου μέσω διαφόρων προσδετών, και στους μεταβολίτες κυνουρενίνης/μεταβολίτες που μοιάζουν με κυνουραμίνη αυτών των παραγόντων, την παρασκευή αυτών και φαρμακευτικές συνθέσεις που περιέχουν αυτές τις ενώσεις. Η εφεύρεση αυτή περαιτέρω κατευθύνεται στη φαρμακευτική χρήση των ενώσεων για την αναστολή GSK3β κινάσης ή/και τη ρύθμιση δραστικοτήτων διαύλων Ν-μεθυλ-D-ασπαρτικού (NMDA) για τη θεραπευτική αγωγή νευροεκφυλιστικών και άλλων διαταραχών.This invention is directed to substituted aryl compounds which bind to a substituted indole moiety through various ligands, and to cynurenine metabolites / cynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing them. This invention is further directed to the pharmaceutical use of the compounds for the inhibition of GSK3β kinase and / or the modulation of N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.

CY20141100822T 2006-10-03 2014-10-10 Substituted aryl-indole compounds and the kinurenine metabolites / metabolites that resemble their cynuramine as therapeutic agents CY1115636T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84864206A 2006-10-03 2006-10-03
EP07859335.7A EP2086932B1 (en) 2006-10-03 2007-10-03 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

Publications (1)

Publication Number Publication Date
CY1115636T1 true CY1115636T1 (en) 2017-01-04

Family

ID=58461616

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100822T CY1115636T1 (en) 2006-10-03 2014-10-10 Substituted aryl-indole compounds and the kinurenine metabolites / metabolites that resemble their cynuramine as therapeutic agents

Country Status (1)

Country Link
CY (1) CY1115636T1 (en)

Similar Documents

Publication Publication Date Title
CY1122048T1 (en) PROTEIN
WO2008041140A3 (en) Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
CY1114669T1 (en) Substituted Sulfonamide Derivatives
CY1114091T1 (en) FACTORS FOR PREVENTION AND TREATMENT OF DISORDERS INCLUDING DIFFERENCE OF RYR TYPES
CY1120903T1 (en) AMINOPYRYDYLOXYPYRASOL COMPOUNDS
NO20073790L (en) Chemical connections
NO20073788L (en) Chemical connections
CY1110977T1 (en) Substituted Indole derivatives for pharmaceutical composition for respiratory disease treatment
CY1114539T1 (en) The usefulness of imidazopyridazinecarbonitriles as suspended kinases
CY1111143T1 (en) NEW CYAN PYRIDINE PRODUCER USEFUL IN TREATMENT OF CANCER AND OTHER DISORDERS
CY1119077T1 (en) PYRAZYLYLAMIN PYRIDENE PRODUCERS USEFUL AS CHINASE Suspensions
CY1115262T1 (en) TRPV1 COMPETITORS AND THEIR USES
CY1113386T1 (en) PROJECTOR SUSPENSIONS
EA200970156A1 (en) PYRDISINOUS DERIVATIVES
CY1118231T1 (en) COMPOSITION OF Liposome
EA201170276A1 (en) TGR5 RECEPTOR MODULATORS AND METHODS OF THEIR APPLICATION
EA200900048A1 (en) NEW CARBONYLATED (AZA) CYCLOGEXANES AS D3 DIGAMINE RECEPTOR LIGANDS
CY1111203T1 (en) 4-ANILINOKINOLINO-3-CARBOXAMIDE AS MOVEMENT INHIBITORS CSF-1R
EA201070786A1 (en) BENZOFUROPYRIMIDINONES
CY1110489T1 (en) ISKINOLIN PRODUCTS
EA201390908A1 (en) DERIVATIVES OF BICYCLO [3.2.1] OCTYLAMIDE AND THEIR APPLICATION
EA200601798A1 (en) MORPHOLIN SUBSTITUTED CONNECTIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
CY1112095T1 (en) Substituted Cyclohexane Spirocyclic Derivatives
CY1125348T1 (en) NEW BRADYKININ B2 RECEPTOR ANTAGONISTS
CY1116168T1 (en) TOY CCR3 HYPERCELLULATORS AND SALT SALTS